Fluoroestradiol PET Imaging in Predicting Response to Hormone Therapy of Breast Cancer
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
Compare the response rate after 6 months of hormone treatment (or a major change in hormone
treatment) in metastatic breast cancer, according to the uptake of FES in metastatic lesions
taking-up FDG on PET/CT at baseline. Hypothesis: best response rate will be observed in
patients with all metastases taking up FES prior to treatment.